Mitoxantrone in malignant pericardial effusion

Journal of Chemotherapy

Volumn 10, Issue 5, 1998, Pages 399-404

  Norum, J ^a   Lunde, P ^a   Aasebo U ^a   Himmelmann, A ^a  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

Author keywords

Malignant pericardial effusion; Mitoxantrone; Pericardial effusion

Indexed keywords

MITOXANTRONE;

ADOLESCENT; ARTICLE; BREAST CANCER; CHILD; CLINICAL ARTICLE; HUMAN; INTRAPERITONEAL DRUG ADMINISTRATION; OVARY CANCER; PERICARDIAL EFFUSION; PERICARDIOCENTESIS; PERICARDIUM; TREATMENT OUTCOME;

EID: 0031740315     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.1998.10.5.399     Document Type: Article

References (12)

1. Rosenthal DS, Braunwald E. Hematologic disorders and heart disease. In: Braunwald E, ed., Heart disease. A textbook of cardiovascular medicine. Philadelphia: WB Saunders, 1980: 1784-7.
2. Posner MR, Cohen GI, Skarin AT. Pericardial disease in patients with cancer. Am J Med 1981; 71: 407-13.
3. Wilkes JD, Fidias P, Vaickus L, Perez RP. Malignancy related pericardial effusion. 127 cases from the Roswell Park Cancer Institute. Cancer 1995; 76: 1377-87.
4. Laham RJ, Cohen DJ, Kuntz RE, Baim DS, Lorell BH, Simons M. Pericardial effusion in patients with cancer: outcome with contemporary management strategies. Heart 1996; 75: 67-71.
5. Winters WL, Cortes FM. Pericardial disease. In: Conn HL, Horwitz O. Cardiac and vascular disease. Philadelphia: Lea and Febinger, 1971: 1328-87.
6. Vaitkus PT, Herrmann HC, LeWinter MM. Treatment of malignant pericardial effuion. JAMA 1994; 272: 59-64.
7. Kohnoe S, Maehara Y, Takahashi I, et al. Intrapericardial mitomycin-C for the management of malignant pericardial effusion secondary to gastric cancer. Case report and review. Chemotherapy 1994; 40: 57-60.
8. Tomkowski WZ, Filipecki S. Intrapericardial cisplatin for the management of patients with large malignant pericardial effuion in the course of the lung cancer. Lung Cancer 1997; 16: 215-22.
9. Aasebø U, Norum J, Sager G, Slørdal L. Intrapleurally instilled mitoxantrone in metastatic pleural effuions: a phase II study. J Chemother 1997; 9; 106-11.
10. Mahrer EA, Shepherd FA, Todd TJR. Pericardial sclerosis as the primary management of malignant pericardial effusion and cardiac tamponade. J Thorac Cardiovasc Surg 1996; 112: 637-43.
11. Lerner-Tung MB, Chang AYC, Ong LS, Kreiser D. Pharmacokinetics of intrapericardial administration of 5-fluorouracil. Cancer Chemother Pharmacol 1997; 40: 318-20.
12. Kuhn K, Purea H, Selbach J, Westerhausen M. Treatment with locally applied mitoxantrone. Acta Med Austriaca 1989; 16: 87-90.